Excerpts from recent editorials in the United States and abroad: ___ Nov. 9 The Washington Post says TrumpRx isn't the best way to lower prices In a landmark deal announced Thursday, President Donald ...

For most of Big Pharma, drug discounts have largely been about damage control. After months of tariff threats and talk of ...

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them ...

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

A man who fainted in the Oval Office last week was a patient of a weight-loss drug company, according to reports.

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

In November 2025, a photo circulated online that some social media users said authentically showed U.S. President Donald Trump looking on as a man fainted during a White House news conference in ...

The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...

Pfizer Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...

Despite President Trump’s claims, scientists don’t have enough evidence to say acetaminophen use during pregnancy is linked ...

SNL Oval Office cold open recreates the November 6 collapse and turns it into a riff on shutdowns, prices, and elections, ...

A man’s dramatic collapse in the Oval Office last week and Trump officials’ reactions grabbed public attention, inspired ...